JPS6148515B2 - - Google Patents

Info

Publication number
JPS6148515B2
JPS6148515B2 JP53046354A JP4635478A JPS6148515B2 JP S6148515 B2 JPS6148515 B2 JP S6148515B2 JP 53046354 A JP53046354 A JP 53046354A JP 4635478 A JP4635478 A JP 4635478A JP S6148515 B2 JPS6148515 B2 JP S6148515B2
Authority
JP
Japan
Prior art keywords
dihydro
tetrahydro
methylpyridazin
methylquinolin
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53046354A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54138585A (en
Inventor
Katsuo Arimura
Noburo Setoguchi
Tatsu Nakao
Akira Nakanishi
Hiroshi Mikashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP4635478A priority Critical patent/JPS54138585A/ja
Priority to PCT/JP1979/000094 priority patent/WO1979000941A1/ja
Priority to FR7909712A priority patent/FR2423489A1/fr
Priority to IT67808/79A priority patent/IT1119916B/it
Publication of JPS54138585A publication Critical patent/JPS54138585A/ja
Publication of JPS6148515B2 publication Critical patent/JPS6148515B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP4635478A 1978-04-18 1978-04-18 Pyridazine derivative and its preparation Granted JPS54138585A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP4635478A JPS54138585A (en) 1978-04-18 1978-04-18 Pyridazine derivative and its preparation
PCT/JP1979/000094 WO1979000941A1 (en) 1978-04-18 1979-04-13 Pyridazine compounds
FR7909712A FR2423489A1 (fr) 1978-04-18 1979-04-18 Derives de la pyridazine et medicament contenant ces substances
IT67808/79A IT1119916B (it) 1978-04-18 1979-04-18 Composti piridazinici

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4635478A JPS54138585A (en) 1978-04-18 1978-04-18 Pyridazine derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS54138585A JPS54138585A (en) 1979-10-27
JPS6148515B2 true JPS6148515B2 (enrdf_load_html_response) 1986-10-24

Family

ID=12744801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4635478A Granted JPS54138585A (en) 1978-04-18 1978-04-18 Pyridazine derivative and its preparation

Country Status (4)

Country Link
JP (1) JPS54138585A (enrdf_load_html_response)
FR (1) FR2423489A1 (enrdf_load_html_response)
IT (1) IT1119916B (enrdf_load_html_response)
WO (1) WO1979000941A1 (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964433D1 (en) * 1978-10-26 1983-02-03 Akzo Nv A wax composition for entirely or partly replacing carnauba wax or montan wax
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5416485A (en) * 1977-07-08 1979-02-07 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivatives and their preparation
NL7810396A (nl) * 1978-10-17 1980-04-21 Yoshitomi Pharmaceutical Nieuwe pyridazinoverbindingen.

Also Published As

Publication number Publication date
IT7967808A0 (it) 1979-04-18
JPS54138585A (en) 1979-10-27
WO1979000941A1 (en) 1979-11-15
FR2423489A1 (fr) 1979-11-16
IT1119916B (it) 1986-03-19

Similar Documents

Publication Publication Date Title
AU656859B2 (en) Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent
US4666908A (en) 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
BG60428B2 (bg) Бензимидазоли,метод за получаването им и лекарствени средства, които ги съдържат
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する5−ht3 レセプター拮抗剤
JPS6350354B2 (enrdf_load_html_response)
TW200823190A (en) 2-aminocarbonyl-pyridine derivatives
JPS59501362A (ja) 二環式窒素複素環エ−テルおよびチオエ−テルおよびその製薬的使用
JP4939721B2 (ja) 1,4−ジアザビシクロ[3.2.2]ノナンベンズオキサゾール、ベンゾチアゾールおよびベンズイミダゾール誘導体、それらの製造方法および治療用途
JP2010024243A (ja) 緑内障および近視を処置するためのベンゾ[g]キノリン誘導体
AU8311691A (en) 4-alkylimidazole derivatives and anti-hypertensive use thereof
JP3199736B2 (ja) アミノアルキル置換された2−アミノ−5−メルカプトチアジアゾール、その製造及び使用
JPS6148515B2 (enrdf_load_html_response)
JP4292738B2 (ja) インドール誘導体およびその医薬用途
JPH0129190B2 (enrdf_load_html_response)
JP2726999B2 (ja) イミダゾ[2,1−b]ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
HU189562B (en) Process for production of n-allil-5-chlor-n/4,5-dihydro-1/1-imidazol-2-il/-2,1-3-benzotiadiazol-4-amin
KR900006682B1 (ko) 디히드로피리딘과 그 반응 중간체의 제조 방법
JP2546919B2 (ja) 9ーアシルアミノテトラヒドロアクリジン誘導体
JPS59101483A (ja) イソインド−ル誘導体、製造、並びに用途
JPS5872584A (ja) 新規キサンチン誘導体、その製法ならびに抗アレルギ−剤
JP2875605B2 (ja) 3―エキソメチレンピロロ[2,1―b]チアゾール誘導体
JPS6153350B2 (enrdf_load_html_response)
NO871284L (no) Ny optisk aktiv forbindelse.
JPH0273084A (ja) 心臓血管系に作用する化合物
WO1994011363A1 (en) 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivative, process for producing the same, and use thereof